Document is current
Any future updates will be listed below
-
Authors
Rostron, Penelope
Pennance, Tom
Bakar, Faki
Rollinson, David
Knopp, Stefanie
Allan, Fiona
Kabole, Fatma
Ali, Said M.
Ame, Shaali M.
Webster, Bonnie L. http://orcid.org/0000-0003-0930-9314
-
Funding
Funding for this research was provided by:
Royal Society (RG160395)
- License Information
-
More Information
Article History
Received: 2 June 2019
Accepted: 19 October 2019
First Online: 4 November 2019
Ethics approval and consent to participate
: The ZEST study protocol was reviewed and obtained ethical approval by (i) the Zanzibar Medical Research Ethical Committee (ZAMREC); (ii) the “Ethikkomission beider Basel” (EKBB) in Switzerland; and (iii) the institutional review board of the University of Georgia (IRB UGA). The trial has been registered at the International Standard Randomised Controlled Trial Number Register (ISRCTN48837681; http://www.controlled-trials.com/ISRCTN48837681).Written informed consent from parents or legal guardians of participating children was obtained for urine collection and storage, including examination for <i>S. haematobium</i> infections with newly developed diagnostic techniques at a later point in time. School-aged children were offered praziquantel (40 mg/kg) against schistosomiasis free of charge in the frame of the biannual island-wide mass drug administration campaigns.
: Not applicable.
: The authors declare that they have no competing interests.
